Baba's Babies: They're All Grown Up!: Alibaba Health (241 HK) Temperature's Rising!
540 Views31 May 2024 19:41
Ali Health is a beneficiary of the growing online healthcare industry in China. Through its synergistic relationship with parent Alibaba the company is enjoying increased revenue and profitability.
What is covered in the Full Insight:
- Introduction
- Financial Highlights
- Market Landscape
- Strategic Initiatives
- Stock Performance
Boomeranged on Wed, 17 Jul 2024 13:00
Morgan Stanley upgraded the stock to OVERWEIGHT from UNDERWEIGHT with a price target of $4.9 which is 55% higher than yesterday's close. The company was reinstated a BUY at Goldman with a price target of $4.40. The company is gaining traction from its e-commerce platform and the acquisition of advertising rights to Tmall's healthcare category. This should also enhance 3P commission rate.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Rising
David Mudd
Asian Hedge Fund Manager, Long Short Equity, Macro
Price Chart(Sign Up to Access)
- US Banks - Weekly US Bankruptcies Rising, US Consumer Defaults More Risk to Large Banks11 Jul 2024
- Technically Speaking: Breakouts and Breakdowns in HONG KONG (July 10)11 Jul 2024
- June Themes and Thematic Portfolio Review09 Jul 2024
- Baba's Babies: They're All Grown Up!: Alibaba Health (241 HK) Temperature's Rising!31 May 2024
x